A method of bioavailability estimation is presented in which a physiologically based kinetic model of lead kinetics is fit simultaneously to blood and bone lead concentrations after a period of exposure to dietary lead. Optimization of the simultaneous fit, varying only fractional absorption, gives the best estimate of fractional bioavailability for each treatment group. The analysis was applied to data from three separate studies in which rats were fed for 30 consecutive days purified diets containing lead added as lead acetate, mine waste-contaminated test soils, or mine waste itself. Fractional absorption decreased as lead intake increased, regardless of the source of the lead; but the magnitude of this dose dependence was lead source-dependent. There were no differences in lead absorption by male and female rats when lead intake was expressed per unit body weight Fractional absorption varied from 4 to 5%, at low exposure rates (1-2 mg lead/kg/day) when lead acetate was added to the diet, to 0.24% at a high exposure rate (24 mg/kg/day) when a mine waste-contaminated test soil was added to the diet. Comparison of the results of this analysis with the results of a more conventional analysis, in which the bone and blood lead concentrations were separately compared with bone and blood lead concentrations in rats given daily injections of lead acetate intravenously for 29 consecutive days, demonstrated that the standard analysis failed to reveal the dose dependence of fractional absorption. O 1996 Sodety of ToikxJofj The bioavailability of lead from different environmental matrices is known to vary widely (Steele et al., 1990) . A number of bioavailability. studies are in progress or have recently been published (Freeman et ai, 1992 (Freeman et ai, , 1994 Weis etal., 1994; Ghantous et al., 1994) . In a typical study design, a soluble lead salt or lead-containing soil or mine waste is fed to experimental animals for a period of time judged sufficient to achieve reasonable lead concentrations in blood and soft tissues. Concentrations of lead are measured in blood, selected soft tissues, and often in bone at the end of the exposure period. The bioavailability of lead from an oral source is estimated by comparison of tissue concentrations at the end of the oral study with tissue concentrations measured at the end of a series of daily intravenous injections of a soluble lead salt given for the same time period. This method of estimating bioavailability requires multiple experimental studies, and generates a separate estimate for each set of tissue concentrations.
We propose an approach to bioavailability estimation that does not require intravenous soluble salt study groups, and that yields a single estimate based on the combined tissue concentration data for each dose and lead source. The method relies on a physiologically based model of lead kinetic behavior in rats (PBK model) (O'Flaherty, 1991) . The best simultaneous model fit to tissue concentrations from a single study group is achieved by optimizing the value of fractional absorption from the gastrointestinal tract. The optimized value is the best single estimate of bioavailability in that study group.
The method is applied to the results of three studies in which rats were fed lead at various levels in mine waste, mine waste-contaminated soils, or as soluble lead acetate, or were administered lead acetate intravenously, for 30 days. Each data set is analyzed independently to estimate bioavailability, in the case of the oral studies, or as a check on the operation of the model, in the case of the intravenous studies. The results of the first and second studies have been published (Freeman et al., 1992 (Freeman et al., , 1994 . The experimental data are reanalyzed in this paper.
METHODS
Study I (Freeman et aL, 1992) . In the first study, young, rapidly growing male and female Sprague-Dawley rats (7-8 weeks old at the start of the study; 5 rats per sex per treatment group) were given one of two mine waste-containing soils, mixed in the diet to provide a total of 8 different dose levels, for 30 consecutive days. The soils were collected from residential areas in Butte, Montana. The test soils had geometric mean volumebased particle diameters of 48 y.m (Test Soil D and 42 pm (Test Soil FID, with ranges up to 194 and 182 /im, respectively 62, 4.05, 7.82, 16.2, 19.5, 40.5, 78.2, and 195 ppm for the eight treatment groups, four for each test soil (Table 1) . Additional treatment groups (5 rats per sex per group) were given lead acetate mixed in the feed for 30 days to provide five different concentrations selected to bracket the test soil diet lead levels. Dietary lead concentrations were 1, 10, 25, 100, and 250 ppm for the five lead acetate treatment groups.
A control group of five male and five female rats served to establish background tissue lead levels. All rats were fed ad libitum AIN-76 meal (Ziegler Brothers, Gardners, PA) into which the appropriate amounts of test soil or lead acetate had been mixed. Test soils were characterized physically and mineralogically, and the homogeneity and stability of the test soils and solutions during the course of the study were ensured. Clinical status, body weight, and food consumption were monitored throughout the in-life phase of the study. The animals were killed by intraperitoneal injection of sodium pentobarbital on the 30th day of the study. At termination, blood, bone (right femur), and liver were taken from all rats for lead analysis.
Study II (Freeman et aL, 1994) . In the second study, young male and female Sprague-Dawley rats (7-8 weeks old at the start of the study; 5 rats per sex per treatment group) were given either one of three different concentrations of lead acetate mixed in the feed for 30 days, or daily intravenous injections of lead acetate for 29 consecutive days. Inclusion of the intravenous treatment group allowed absolute lead bioavailability to be calculated for both oral lead acetate and the previously tested mine waste soils, since intravenous lead was presumed to be 100% bioavailable. All rats were fed ad libitum AIN-76 meal into which the appropriate amounts of lead acetate had been mixed. Dietary lead concentrations were 1, 25, and 250 ppm for the three treatment groups. Dose rates were 0.02, 0.20, and 2.0 mg lead/kg body weight/day for the three intravenous treatment groups. The daily intravenous dose was given by injection into the lateral tail vein. The design and conduct of the study were the same as those of Study I.
Study III (Freeman et aL, 1993) . The test substances were four different mine wastes. Three (B1-B3) were composites taken either from the surface of a single tailings pile or from a nearby creek channel (the Bingham Creek area in Utah). The fourth (B4) was a waste composite taken from the interior of a tailings pile located in Butte, Montana. The bulk samples were dried, sieved to exclude particles >250 (im, homogenized, and separated into subsamples for soil and mineralogic characterization and for the rat feeding studies. The geometric mean volume-based particle diameters of the mine wastes were 38 /im (Bl), 23 ^m (B2), 21 urn (B3), and 23 ixm (B4), with ranges up to 253, 253, 253, and 300 fim, respectively.
Young male Sprague-Dawley rats (7-8 weeks old at the start of the study; 6 rats per dose group) were given one of the four mine wastes, mixed in the diet to provide three dose levels of each waste, for 30 days. In addition, male rats (7-8 weeks old at the start of the study; 8 rats per dose group) were given daily intravenous injections of lead acetate for 29 days. All rats were fed ad libitum AIN-76 meal into which the appropriate amounts of the mine wastes had been mixed. Doses were 5, 10, and 20 ppm lead in the diet for the mine wastes, and 0.2, 1.0, and 2.0 mg lead/kg body weight/day for intravenous administration. The daily intravenous dose was given by means of an indwelling venous catheter. The design and conduct of the study were the same as those of Study I.
Kinetic modeling. The physiologically based model of lead kinetics has been described in detail (O' Flaherty, 1991) . It incorporates rat body and bone growth from birth on, and takes into account growth-related increases in organ and tissue volumes as well as the age-dependent mechanisms by which lead is assimilated into and released from bone. Input data for the simulations were the background exposure, measured body weights, feed consumption, concentration of lead in feed, age of the rats when the experiment was started, and duration of controlled exposure. Model growth curves, which determine organ and tissue weights and the values of physiologic functions, were based on the recorded body weights of male and female rats in each study. Feed consumption curves, together with the concentration of lead in feed, gave the daily intake of lead for males and females in each dose group.
The value of fractional absorption during the period of controlled oral lead administration was determined by visually optimizing the model simulation for growing rats of the experimental sex, age, and body weight range, given lead for 30 days at the experimental daily rate in addition to their background exposure, to the experimental lead concentrations in blood and bone. Fractional absorption was the only parameter whose value was varied in the optimization process. All other model parameter values were held constant, or were assigned their default age and body-weight dependencies, during the optimization process.
As an independent check on model performance, the intravenous experiments were modeled by simulating 29 consecutive daily injections of lead acetate and assuming 100% bioavailability. 
RESULTS
Body weights during the controlled exposure period were independent of treatment group in all three studies. Figure  I illustrates the fit of the model growth curve to the mean body weights for male rats in Study I. This growth curve, which establishes organ and tissue weights, blood flows, and excretion rate as functions of rat age, is a key determinant of the output of the model. Use of an experimentally determined growth curve allows the simulations to be tailored to the specific group of rats in each study. From the model with fractional absorption set at its default value of 1 % for rats consuming a typical mixed diet, background exposure to lead in food, drinking water, and air from birth until day of termination of the controlled exposure was determined to have been equivalent to dietary levels between 0.6 and 1.0 ppm in the three studies, had the diet been the only source of lead. This background was included in each simulation as a continuous dietary exposure from birth until the end of the study.
Experimental and predicted blood lead concentrations in the intravenous lead acetate groups from Studies II and HI agreed well, validating this application of the model and confirming that the injected lead was close to 100% bioavailable (Fig. 2) . Simulated bone lead concentrations for intravenous lead acetate groups, however, were consistently lower than measured femur concentrations. Figure 3 , again from Studies II and ITI, illustrates the differences. Interpretation of this disparity is complicated by the fact that the model simulates a mean bone lead for the entire skeleton, while measurements were made on a single bone, the femur. In addition, factors related to the nature of the injection itself could have influenced the distribution of lead in the intravenous lead acetate groups (see Discussion).
Figures 4 and 5, for the Study I male and female rats given mine waste-containing soils mixed in the diet, illustrate the general quality of the optimized model fits to blood and bone lead concentrations in the various dietary lead groups. From the eight dietary levels, the two lowest are excluded for males and the three lowest for females because blood lead concentrations in these groups were similar to or below blood lead concentrations in the control groups. The simulated concentrations of lead in blood and bone were success- fully fit simultaneously to the experimentally measured blood and bone concentrations at each dose level.
Application of the standard method for estimation of bioavailability, by comparison of individual measured blood and bone lead concentrations in Study I test soil treatment groups to concentrations estimated by interpolation between measured blood and bone lead concentrations in the Study II intravenous lead acetate groups, yields the percentage bioavailability values shown in Table 1 . The three highest test soil dose levels for the male rats, and the four highest for the female rats, were excluded from this calculation because they would have required extrapolation of the reference (intravenous lead acetate) tissue concentrations beyond the range of actual measurement. Fractional absorption calculated in this way is independent of test soil, sex, and dose level, and is dependent on the tissue used for the calculation. Table 1 also gives the values of percentage bioavailability estimated by visual optimization of the physiologically based model fit to combined tissue concentrations at each test soil dose level. In both males and females, lead bioavailability was not different between the two test soils. However, fractional absorption determined in this manner decreases smoothly as lead concentration increases.
In all treatment groups (Table 1) , the female rats appear to have absorbed a smaller fraction of dietary lead than the males. However, within each treatment group the females were smaller, and consumed more food per unit body weight, than the males. When the percentage of absorption is related to actual lead intake per unit body weight instead of to nominal exposure, as shown in Fig. 6 , it is clear that fractional absorption of lead from the mining waste soils is not different for males and females. The overall dose dependence of fractional absorption is striking. At the lowest intake rate usable for this calculation, 0.680 mg/kg/day in male rats, 1.6% of the mine waste-containing soil lead was absorbed. At the highest intake rate, 23.8 mg/kg/day in female rats, only 0.24% was absorbed. Table 2 presents the same comparison of bioavailability, as calculated by the standard and PBK methods, for the oral lead acetate-treated rats in Studies I and II. As for the mine waste soils, estimates of bioavailability made by the standard method are tissue-dependent but neither dose-nor sex-dependent. In contrast, estimates of bioavailability made by the PBK method are dose-dependent, although not as markedly nor as consistently as in the mine waste-contaminated test soil studies (Fig. 7) . As expected, lead is more bioavailable from lead acetate than from the mine waste-containing soils. At the lowest intake rate, 0.732 mg/kg/day in male rats, 3.9% of the lead was absorbed, although estimated absorption was actually 4.8% at a slightly higher dose rate. At the highest intake rate, 26.2 mg/kg/day in female rats, 1.7% of the lead was absorbed.
A summary of the results of Study III is given in Table  3 . Percentage absorption calculated by the PBK method consistently decreases with increasing dose even within the relatively narrow dietary lead concentration range in this study. Lead appears to be somewhat more bioavailable from mine waste B3 than from the other three mine wastes, which behave very much like the mine waste test soils used in Study I. The difference between B3 and the other three mine wastes is also apparent when the bioavailability calculation is made using the standard method (Table 3) , although again with this method no consistent dose dependence is detectable.
DISCUSSION
A purified diet was selected for these studies in order to minimize background lead exposure and maximize fractional absorption from the controlled lead source. The nutritionally complete ATN-76 diet, which more closely simulates the low-fiber diets of most U.S. adults than does rat chow, maximizes lead absorption because it is relatively low in calcium. Since calcium and lead are absorbed through similar mechanisms, homeostatic regulation of calcium absorption results in greater fractional absorption of both calcium and lead from low-calcium diets (Mahaffey et al., 1973) . High-calcium rat chow diets, in contrast, attenuate the bioavailability of lead.
Particle size is also a key factor mediating lead bioavailability. Barltrop and Meek (1979) showed that fractional lead absorption from metallic particles in the rat gastrointestinal tract was decreased as particle size increased within a size range of 5-200 /xm mean particle diameter. Particle size ranges were restricted in the current study in order to approximate the range of soil particle sizes typically ingested by children (Duggan et al., 1985) . The geometric mean volume-based particle diameters of all the test substances are within the metallic particle size range reported by Barltrop and Meek (1979) to favor high fractional absorption. Bioavailability of lead from a limited size range of small leadcontaining particles incorporated into a purified diet matrix would be expected to be maximized. Dose-dependent bioavailability of lead from the rat gastrointestinal tract has been reported before. It has been most strikingly demonstrated in fasted adult rats, in which fractional absorption of a single oral 1 mg/kg dose of soluble lead was found to be 42% (Aungst et al., 1981) . Only at a dose of 100 mg/kg was fractional absorption around 1-2%, of the order of those estimated for the 10-30 mg/kg lead acetate treatment groups in the present study. These figures are consistent with the finding that lead is also much better absorbed by humans in the fasted than in the fed state (Rabinowitz et al., 1980) . The present study represents the first documentation of a consistent dose dependence of fractional bioavailability of both soluble lead and lead embedded in a mineral matrix, in fed rats. The observed dose dependence is less pronounced for lead acetate than it is for lead in mine waste or in mine waste-contaminated soils. This difference is consistent with the suggestion of Chaney (1991) that soils present in the gastrointestinal tract may adsorb lead, rendering it unavailable for absorption. However, in Study I, increases in dietary lead concentration were not always accompanied by corresponding increases in dietary soil concentration (Table 1) . While the data in Table 1 are not inconsistent with the concept that the amount of soil in the gastrointestinal tract may be an important determinant of lead bioavailability, the observed smooth decrease in fractional bioavailability with increasing dietary lead concentration (Fig. 6) determined at least in part by factors acting in addition to any effect of adsorption onto soil.
The mine wastes and mine waste-containing soils tested in these studies represent a spectrum of lead-containing soil contaminants. The test soils in Study I were composite residential soils that had been subjected to natural weathering processes and may have contained lead from other sources in addition to mine waste. The mineral composition and metal concentrations of the two soils were distinctly different (Freeman et ai, 1992) , but the geometric means and standard deviations of the soil particle diameters were similar. Bioavailability of lead from the two soil matrices was also not different. Bioavailability of lead from residential soils is of the greatest environmental concern from the point of view of exposure of children playing in contaminated areas. However, there also is interest in the bioavailability of lead from matrices more closely representative of the mine waste itself. In Study III, mine wastes were mixed directly with the diet. Samples Bl -B3 had been subjected to weathering and leaching at the surface of the tailings pile and stream bed. Sample B4, from the interior of the tailings pile, was representative of "pure" mine waste, uncontaminated by other sources and not subjected to weathering. The bioavailability of lead from Sample B3 was greater than that from the other mine waste samples (Table 3) . Sample B3, from the creek bed adjacent to the tailings pile from which Samples Bl and B2 were collected, had a higher pH (~5) than Samples Bl and B2 (~2.6), and a different mineralogic composition. Sample B4 was similar in its composition to the residential test soils in Study I. Application of a kinetic model in order to estimate bioavailability from a single set of data collected at the end of a study period requires the assumption that fractional absorption has been essentially constant during the study. Fractional absorption is known to be dependent on age in very young rats. It is high prior to weaning and declines thereafter. Forbes and Reina (1972) , however, showed that this decline occurs very rapidly and that fractional absorption has stabilized at adult levels by age 30 days (Fig. 8) . Therefore, the assumption that fractional bioavailability is essentially constant in rats 7-8 weeks old and older is reasonable. Thirty days is sufficient time to allow achievement of an approximate steady state between lead in blood and lead in soft tissues. However, lead is not near steady state in bone after only 30 days. The bone to blood lead concentration ratios are lower in these animals than they would have been if exposure had been allowed to continue to achievement of steady state. The tables show that bioavailability as estimated by the standard method is consistently lower when bone concentrations are used as the basis for the calculation than when blood concentrations are used. Possibly, the non-steady-state conditions in bone contribute to some extent to this difference. Of greater probable importance in this regard, however, are the high bone lead concentrations in the intravenous dose groups, which were invariably underpredicted by the PBK model. Model behavior was consistent with both blood and bone lead concentrations in the oral dose groups in these studies. A possible explanation for the discrepancy between predicted and actual bone lead concentrations in the intravenous lead acetate groups is that on intravenous injection, equilibration of lead between plasma and the red cell cannot keep pace with the rapid influx of lead into the blood plasma. This equilibration process has been shown to require several minutes in vitro (Simons, 1993) . Furthermore, the equilibrium ratio is concentration-dependent. At low total blood lead concentrations, the red cell contains at least 99% of the lead in the blood; but binding in the red cell is capacity-limited, so that the fraction of blood lead that is in the red cell at equilibrium decreases with increasing blood lead concentration (Klaassen and Shoeman, 1974) . Both these factors-concentration dependence and time dependence-would tend to shift blood lead away from the red cell and toward the plasma and, consequently, to shift the uptake of lead toward peripheral tissues, including bone, during periods of very rapid entry of lead into the plasma.
Estimation of fractional bioavailability of lead by the PBK model method has revealed an internal coherence of these data sets that was not apparent when the standard method was used for estimating bioavailability. This outcome, suggesting that an integrated approach to interpretation of tissueand time-dependent concentration measurements is worthwhile, supports use of a PBK model for this purpose. The new approach offers several additional advantages over the traditional method now in use:
1. Since direct tissue concentration comparisons between oral and intravenous routes of administration are not made, there is no requirement that the oral dose levels of interest must be bracketed by intravenous doses that generate the same range of ending tissue concentrations.
2. Without the requirement for intravenous dose groups, fewer animals need be used, and invasive techniques are not required.
3. Fractional bioavailability is calculated directly for each oral dose. Rather than multiple estimates of bioavailability for each treatment group, the aggregate information from a single treatment group generates the single best estimate of fractional bioavailability at that dose level.
4. Blood and tissue lead levels need not be at steady state, nor even at approximate steady state. Physiologically based models are capable of simulating dynamic as well as steadystate kinetics.
The potential for extension of this methodology to other agents and to other experimental or observational situations in which exposure is known or controlled and tissue concentrations have been measured is apparent. Once validated, physiologically based models can be applied in other studies in which it is desired to estimate the magnitude of a particular physiologic process. By integrating all the available experimental information into a single model structure that reflects the function of the total system, the physiologically based model can assist in illuminating and clarifying the relationships among key determinants of kinetic behavior.
